Forsyth Barr keeps 'underperform' for F&P Healthcare

Forsyth Barr keeps 'underperform' for F&P Healthcare
The past year had been a welcome change from the pandemic, chair Scott St John told shareholders. (Image: NZ Herald)
Staff reporters
Forsyth Barr has kept its underperform rating for Fisher & Paykel Healthcare because new earnings guidance medical products maker had provided “little new information”. In a note on Wednesday, analysts Matt Montgomerie and Benjamin Crozier said the earnings guidance update Fisher & Paykel gave to the market and shareholders on Tuesday provided “little new information to fundamentally change our view on the earnings outlook”.Fisher & Paykel Healthcare told the market and then its shareholde...